newest glp-1 drug Eli Lilly to seek approval of new weight-loss this year Novo's Wegovy becomes first GLP-1

Ludvik B, Giorgino F, Jodar E, Frias JP, Fernandez Lando L, Brown K, et al

In fact, CVOTs have shown that in patients without a history of HF but with high cardiovascular risk, GLP-1 RAs led to a 15% reduction in the composite outcome of cardiovascular death and hospitalisation for HF

Two habits carry most of the protection

In fruit flies and rats, some studies observed a reduction in age-related mortality indices, and in specific mouse strains predisposed to cardiovascular and oncologic conditions, trends toward longer survival were reported under defined conditions

- Stable Gastric Pentadecapeptide BPC 157 and Wound Healing - BPC-157 Peptide Therapy: Healing from the Inside Out - Why BPC-157 is One of the Most Popular Peptides in Regenerative